Charlotte Beaudart

At a glance

• Belgian researcher in the Public Health Aging Research & Epidemiology (PHARE) group at the University of Namur.
• Specialises in sarcopenia: the loss of muscle mass, strength and function with age. Her work includes meta-analyses on the health consequences of sarcopenia and on how nutrition and exercise help prevent and treat it.
• Contributes to international consensus groups on how sarcopenia is defined and measured, and to research on osteoporosis, fracture risk and quality of life in older adults.
• In 2026 she was first author of a systematic review and meta-analysis on GLP-1 drugs (such as semaglutide) and muscle and bone outcomes — timely now that many people lose weight with these medicines.
• Her work combines epidemiology with quality of life and patient preferences: not just whether an approach works, but what it means in older people’s daily lives.
• Relevant to longevity because muscle strength is one of the strongest predictors of healthy, independent ageing.